Regulatory science: What it is and why we need it

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 2, 2011, Pages 291-294

  Fitzgerald, G A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG APPROVAL; DRUG DESIGN; DRUG INDUSTRY; DRUG LEGISLATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; PATIENT CARE; PHARMACOGENETICS; PRIORITY JOURNAL;

HUMANS; PUBLIC HEALTH; SCIENCE; TRANSLATIONAL RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78951490294     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.276     Document Type: Article

References (19)

1. Grosser, T., Yu, Y. & fitzgerald, G.A. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu. Rev. Med. 61, 17-33 (2010).
2. Grosser, T., Fries, S. & fitzGerald, G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J. Clin. Invest. 116, 4-15 (2006).
3. Editorial: Meta-analysis and moderation. Nat. Rev. Drug Discov. 9, 747 (2010).
4. Woodcock, J., Sharfstein, J.M. & Hamburg, M. Regulatory action on rosiglitazone by the U.S. Food and Drug administration. N. Engl. J. Med. 363, 1489-1491 (2010).
5. Fitzgerald, G.A. Clinical pharmacology or translational medicine and therapeutics: reinvent or rebrand and expand? Clin. Pharmacol. Ther. 81, 19-20 (2007).
6. Wellcome Trust. Translational Medicine and Therapeutics programmes. http://www.wellcome.ac.uk/News/Media-office/Press-releases/2008/ WTX049865.htm.
7. Skarke, C. & fitzGerald, G.A. Training translators for smart drug discovery. Sci. Transl. Med. 2, 26cm12 (2010).
8. FitzGerald, G.A. Perestroika in pharma: evolution or revolution in drug development? Mt. Sinai J. Med. 77, 327-332 (2010).
9. US food and Drug administration. FDA Science and Mission at Risk: Report of the Subcommittee on Science and Technology http://www.FDA.gov/ ohrms/dockets/ac/07/briefing/2007-4329b-02-01-FDA%20Report%20 on%20Science%20and%20Technology.pdf (November 2007).
10. National Institutes of Health. NIH and FDA announce Collaborative Initiative to fast-track Innovations to the Public. http://www.nih.gov/news/ health/ feb2010/od-24.htm (2010).
11. The Health Bill's Cures for Research. http://news.sciencemag.org/ scienceinsider/2010/03/the-health-bills-cures-for-resea.html (2010).
12. US food and Drug administration. Advancing Regulatory Science for Public Health. A framework for FDA's Regulatory Science Initiative. http://www.FDA.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ ucm228131.htm.
13. Lebowitz, Y., English, R. & Clairborne, A. Building a National Framework for the Establishment of Regulatory Science for Drug Development (National academies Press, Washington DC, In press).
14. Regulatory Science Program, University of Southern California. http://regulatory.usc.edu/.
15. Institute of Regulatory Sciences. http://www.nars.org/index.html.
16. Center for Science and Technology Policy Research. Regulatory vs. Academic Science. http://sciencepolicy.colorado.edu/klamathbasin/science-policy/ regulatory-vs-academic.html .
17. CTSciNet. All in the Details: Careers in Regulatory Science. http:// sciencecareers.sciencemag.org/career-magazine/previous-issues/ articles/2010-04-09/caredit.a1000037 (2010)
18. CTSa Consortium. Clinical and Translational Science awards program. http://www.ctsaweb.org/index.cfm?fuseaction=quicklink.showSGC.
19. Hughes, M.E., Peeler, J. & Hogenesch, J.B. Network dynamics to evaluate performance of an academic institution. Sci. Transl. Med. 2, 53ps49 (2010).